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Fortasyn Connect (FC) is a speciﬁc nutrient combination designed to target synaptic dysfunction in
Alzheimer’s disease by providing neuronal membrane precursors and other supportive nutrients. The
aim of the present study was to investigate the effects of FC on hippocampal cholinergic neurotrans-
mission in association with its effects on synaptic membrane formation in aged rats. Eighteen-month-old
male Wistar rats were randomized to receive a control diet for 4 weeks or an FC-enriched diet for 4 or
6 weeks. At the end of the dietary treatments, acetylcholine (ACh) release was investigated by in vivo
microdialysis in the right hippocampi. On completion of microdialysis studies, the rats were sacriﬁced,
and the left hippocampi were obtained to determine the levels of choline, ACh, membrane phospho-
lipids, synaptic proteins, and choline acetyltransferase. Our results revealed that supplementation with
FC diet for 4 or 6 weeks, signiﬁcantly enhanced basal and stimulated hippocampal ACh release and ACh
tissue levels, along with levels of phospholipids. Feeding rats the FC diet for 6 weeks signiﬁcantly
increased the levels of choline acetyltransferase, the presynaptic marker Synapsin-1, and the post-
synaptic marker PSD-95, but decreased levels of Nogo-A, a neurite outgrowth inhibitor. These data show
that the FC diet enhances hippocampal cholinergic neurotransmission in aged rats and suggest that this
effect is mediated by enhanced synaptic membrane formation. These data provide further insight into
cellular and molecular mechanisms by which FC may support memory processes in Alzheimer’s disease.
 2015 The Authors. Published by Elsevier Inc. All rights reserved.1. Introduction
Synapse loss and membrane-related pathology play a central role
in the pathogenesis of Alzheimer’s disease (AD) (Arendt, 2009;
Selkoe, 2002) and consequently provide viable intervention targets.
In early AD, the increased synapse loss is associated with memory
decline (Selkoe, 2002; Sperling et al., 2011; Terry et al., 1991).
Reducing synapse loss and membrane-related pathology may pre-
serve or improve neurotransmission and, thereby, positively affect
memory and other cognitive functions.
Fortasyn Connect (FC) is a speciﬁc nutrient combination
designed to ameliorate synapse loss and synaptic dysfunction in AD
(Van Wijk et al., 2014) by addressing nutritional needs believed to
exist in these patients (Lopes da Silva et al., 2013; Mi et al., 2013). FC
comprises precursors and cofactors required for the formation andC BY-NC-SA license (http://
acology, Uludag University
ey. Tel.: þ90 224 295 3568;
v).
Published by Elsevier Inc. All righmaintenance of neuronal membranes, that is, uridine (as uridine
monophosphate, UMP), the omega-3 PUFAs docosahexaenoic acid
(DHA) and eicosapentaenoic acid, choline, phospholipids, folic acid,
vitamins B12, B6, C, and E, and selenium.
FC is present in Souvenaid, a medical food intended for early
AD patients. This medical food signiﬁcantly improved memory
performance in drug-naïve patients with mild AD in 2 recent
clinical trials (Scheltens et al., 2010, 2012). In addition, electro-
encephalography measures suggested that the medical food pre-
served functional brain network organization, counteracting the
pattern usually seen in AD patients (deWaal et al., 2014; Scheltens
et al., 2012).
The aim of the present study was to further investigate the
physiologicalmechanismunderlying the cognitive enhancingeffect of
FC by supplementing aged rats with a diet enriched with this speciﬁc
nutrient combination. It is been well established that improved
learning and memory in various tasks is associated with augmented
cholinergic neurotransmission in the hippocampus (Fadda et al.,
2000; Nail-Boucherie et al., 2000). Therefore, we assessed the effect
of an FC-enriched diet on acetylcholine (ACh) release, indicative of
hippocampal cholinergic neurotransmission, by in vivo microdialysists reserved.
Fig. 1. Timeline of the experimental protocol. To perform microdialysis on each rat on separate days, termination of the experimental procedures for each group was arranged to 3
consecutive weeks by arranging the onset of dietary treatments accordingly: dietary treatment for control and FC diet 6 weeks groups was initiated on the same day whereas
dietary treatment for FC diet 4 weeks group was initiated 1 week later. Abbreviation: FC, Fortasyn connect.
Table 1
Detailed compositions of the 2 experimental diets
Ingredients (g/100 g diet) Diets
Control Fortasyn
Cornstarch, pregelatinized 35.6 32.5
Caseine 14.0 14.0
Maltodextrin, 10 DE 15.5 15.5
Sucrose 10.0 10.0
Dextrose 10.0 10.0
Soy oil 1.900
Coconut oil 0.900 0.100
Corn oil 2.200 1.700
Fish oil 3.200
Cellulose powder 5.0 5.0
Mineral mix (AIN-93M-MX) 3.5 3.5
Vitamin mix (AIN-93-VX) 1.0 1.0
L-cystine 0.180 0.180
Choline chloride (50%) 0.230 0.922
Tert-butylhydroquinone 0.0008 0.0008
UMP (UMP disodium salt) 1.0
Soy lecithin 0.755
Vitamin B6 (pyridoxin hydrochloride, 100%) 0.00328
Folic acid (100%) 0.00060
Vitamin B12 (cyanocobalamin, 0.1%) 0.00350
Ascorbic acid (100%) 0.160
Vitamin E (tocopherol acetate, 50%) 0.4650
Selenium (sodium selenite pentahydrate, 100%) 0.00034
Total 100.0 100.0
All amounts of nutrients are indicated in g/100 g of diet.
Key: UMP, uridine monophosphate.
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tigation of the effects of FC on synaptic membrane formation, to
further investigate its mode of action. This is the ﬁrst study to
determine the effect of chronic treatment with this speciﬁc nutri-
tional combination on hippocampal ACh release in association with
its effects on synaptic membranes in aged rats.
We found that dietary supplementation with FC diet for 4 or
6weeks signiﬁcantly enhanced hippocampal ACh release, both under
basal conditions and after atropine stimulation. This observationwas
accompanied by enhanced levels of tissue ACh and membrane
phospholipids. In addition, FCdiet treatment for 6weeks signiﬁcantly
increased the levels of choline acetyltransferase (ChAT) and the
presynaptic and postsynaptic markers Synapsin-1 and PSD-95,
respectively, while decreasing levels of Nogo-A, a neurite
outgrowth inhibitor. Hence, the present data show that consumption
of the FC-enriched diet enhances hippocampal cholinergic neuro-
transmission, which probably can be ascribed to the concurrently
observed enhanced synaptic membrane formation.
2. Methods
2.1. Animals
Eighteen-month-old male Wistar rats (Experimental Animals
Breeding and Research Center, Uludag University Medical School,
Bursa, Turkey) were group housed in a temperature controlled
room with free access to standard rat chow and water under a-12/
12 hour light-dark cycle The experimental protocol was approved
by the Animal Care and Use Committee of Uludag University, Bursa,
Turkey (Approval ID: 2012-03/03), and all experiments conformed
to the National Institutes of Health Guide for the Care and Use of
Laboratory Animals (NIH Publications No. 80-23) revised 1996. All
efforts were made to minimize the number of animals used and the
individual level of discomfort.
2.2. Dietary supplementation
Rats were randomized to control and FC diet groups. Rats in the
control group (n ¼ 4) received a regular rat chow for 4 weeks,
whereas rats in the FC groupwere fed the FC diet for either 4 (n¼ 5)
or 6 (n ¼ 5) weeks.
Dietary treatment for control and FC diet 6 weeks groups was
initiated on the same day, whereas dietary treatment for FC diet
4 weeks groupwas initiated 1 week later. With this set-up, wewere
able to performmicrodialysis on each rat on separate days. Timeline
of the experimental protocol is provided in Fig. 1.
Both the control diet and the FC-enriched diet were AIN-93 M
based (Reeves et al., 1993), isoenergetic, and fulﬁlled all dietary
requirements. Both diets contained the standard vitamin mix (AIN-
93-VX) and mineral mix (AIN-93M-MX). The diets differed incompositionwith regard to the fat blends used, as well as a number
of supplemented nutrients, including choline, B-vitamins, antioxi-
dants, UMP, and lecithin. A detailed overview of the contents of
diets is presented in Table 1. The diets were formulated by Nutricia
Research, Nutricia Advanced Medical Nutrition (Utrecht, the
Netherlands), manufactured by Ssniff Spezialdiäten (Soest, Ger-
many) and presented to the animals as pellets. All diets were stored
at 20 C until use, to prevent lipid oxidation. Reanalysis of the
diets at the end of the study conﬁrmed that all fatty acids were still
present in the original amounts.
No signiﬁcant differencewas observed between treatment groups
in terms of mean daily amount of food consumed and weight gain
(data not shown) during the treatment.2.3. Surgical procedures
One day before the completion of dietary treatment, a probewas
inserted in the right hippocampus of rats in each group to perform
in vivo microdialysis. Rats were anesthetized with ketamine and
xylazine (80mg/kg and 10mg/kg, respectively) and then placed in a
stereotaxic frame. Subsequently, skulls were exposed, and a small
hole was drilled over the right hippocampus. A hand-made probe
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length was 1 mm) was implanted in the CA1 region of the hippo-
campus by using Dura at Bregma as the reference point (co-
ordinates were: AP 4.0 mm; ML 2.2 mm; DV 2.6 mm; Paxinos
and Watson, 2004) and then ﬁxed to the skull using acrylic
cement. After surgery the rats were placed in individual cages and
allowed to recover from anesthesia for 24 hours. During this period,
they remained calm and showed no signs of overt discomfort or
pain.
2.4. In vivo microdialysis
In vivo microdialysis experiments were carried out 24 hours
after surgery to avoid effects of anesthesia. The dialysis probe
inserted in CA1 region of the right hippocampus of freely-moving
rats was perfused at a rate of 2 mL/min with artiﬁcial cerebrospi-
nal ﬂuid (pH ¼ 7.4) of the following composition: 148 mM NaCl,
3.0 mM KCl, 1.4 mM CaCl2, 0.8 mMMgCl2, 1.3 mMNaH2PO4, 0.2 mM
Na2HPO4, and neostigmine (1 mM) to block enzymatic degradation
of ACh.
Each microdialysis sample was collected with 30 minutes in-
tervals. Samples collected during the ﬁrst hour of microdialysis
were discarded. After collection of the ﬁrst 3microdialysates, which
were referred to as baseline samples, the perfusion medium was
replaced with another which contained atropine sulfate (10 mM).
This perfusion was continued for 1 hour, and then atropine-
containing medium was replaced with the initial atropine-lacking
medium.
Microdialysis was terminated 6 hours after the start of collecting
the ﬁrst baseline sample, and rats were sacriﬁced under ketamine
and xylazine (80 mg/kg and 10 mg/kg, respectively) anesthesia.
Brains were immediately taken out and the left hippocampi were
obtained, weighed, and homogenized in 50 volumes of ice-cold
deionized water with 10 up-and-down strokes, using a teﬂon-
glass homogenizer (Wheaton, Milville, NJ, USA) to assay levels of
tissue choline and ACh, as well as phospholipids, synaptic proteins,
and ChAT. The placement of microdialysis probes were conﬁrmed in
the right hippocampi of randomly selected rats.
2.5. Analyses of ACh and choline
Levels of choline and ACh in microdialysis samples and hippo-
campal homogenates were analyzed by high performance liquid
chromatography (Hitachi, Tokyo, Japan) equipped with an electro-
chemical detector (Antec BV, Zoeterwoude, the Netherlands). A BAS
ACh/choline analytical column cartridge and post-column enzyme
reactor (MF-6150 and MF-6151) were used at 37 C to separate ACh
and choline. The mobile phase contained 40 mM Na2HPO4, 0.5 mM
Na2EDTA, and 0.5 mL/L Kathon CG at pH 8.4, and the ﬂow rate was
1 mL/min.
2.6. Phospholipid assay
Hippocampal phospholipids were extracted according to the
Folch method (Folch et al., 1957) and measured as described previ-
ously (Cansev and Wurtman, 2007). One mL aliquots of the hippo-
campal homogenates were mixed with 3 mL of a chloroform plus
methanol mixture (2:1 vol/vol) and vortexed for 30 seconds. After
cooling for about 1 hour on ice, each mixture was sequentially
combined with 3 mL of the chloroform plus methanol mixture, and
1mL of ice-cold deionizedwater. It was then vortexed vigorously and
allowed to stand overnight at þ4 C (18e20 hours). The organic
(lower) and aqueous (upper) phases were separated by centrifuga-
tion (10 minutes at þ4 C; 1000 g) and the upper phase was dis-
carded. Aliquots (0.1 and 0.4 mL) of the lower (organic) phase weredried under vacuum for phospholipid analyses. Residues of 0.1 mL
aliquots of the lower phase were assayed for total phospholipids by
measuring phosphorus content (Svanborg and Svennerholm, 1961).
Residues of 0.4 mL aliquots of the lower phase were reconstituted in
40 mL methanol and subjected to thin-layer chromatography using
silica G plates (Adsorbosil Plus-1, Alltech, USA), and a solvent system
consisting of chloroform/ethanol/triethylamine/water (30:34:30:8)
as the mobile phase. Phospholipid standards (Sigma, St. Louis, MO,
USA) were used to identify the corresponding bands under UV
light after the plates were sprayed with 0.1% diphenylhexatriene in
petroleum ether. Bands for individual phospholipid classes (phos-
phatidylcholine [PC], phosphatidylethanolamine [PE], phosphati-
dylserine [PS], phosphatidylinositol [PI], and sphingomyelin [SM])
were scraped off the plates and extracted into 1 mL of methanol,
dried under vacuum, and assayed for phosphorus content (Svanborg
and Svennerholm, 1961).
Aliquots of hippocampal homogenates were assayed for total
protein using a bicinchoninic acid reagent (Perkin Elmer, Norwalk,
CT, USA). Phospholipid levels were expressed as nmol/mg protein.
2.7. Western blot analysis
Synaptic proteins were assayed by Western blot as previously
described (Sakamoto et al., 2007; Wurtman et al., 2006). Brieﬂy,
aliquots of hippocampal homogenates were mixed with equal
volumes of Laemmli loading buffer and boiled before gel electro-
phoresis. Equal amounts of protein were loaded and separated us-
ing SDS-PAGE (4%e20%; Bio-Rad, Hercules, CA, USA). Proteins were
then transferred onto polyvinylidene ﬂuoride membranes (Milli-
pore, Billerica, MA, USA). The remaining binding sites were blocked
with 4% nonfat dry milk (Carnation, Glendale, CA, USA) for 30 mi-
nutes in Tris-Buffered Saline and Tween 20 (TBST). Membranes
were then rinsed 5 times in TBST buffer and incubated overnight in
TBST solution containing the primary antibody of interest (goat
anti-PSD-95 [Abcam, Cambridge, MA, USA; ab90426], rabbit anti-
synapsin-1 [Abcam; ab18814], and rabbit anti-Nogo-A [Abcam;
ab62024]). Next day, blots were incubated for 1 hour with the
appropriate peroxidase-linked secondary antibody followed by
detection and visualization of protein-antibody complexes using
the enhanced chemiluminescence system (GE Healthcare Bio-
sciences, Pittsburgh, PA, USA) and Kodak X-AR ﬁlms which were
digitized using a Supervista S-12 scanner (UMAX Technologies,
Freemont, CA, USA). Immunoreactive bands were compared den-
sitometrically using the Public Domain NIH Image program avail-
able at http://rsb.info.nih.gov/ij/ according to the instructions of the
software. Membranes were stripped using a stripping buffer
(Thermo Fisher Scientiﬁc, Rockford, IL, USA) and then incubated
with b-tubulin antibody (mouse anti-b-tubulin [Sigma; T5076])
used as the loading control.
2.8. ChAT level assay
ChAT levels were determined using an enzyme-linked immuno-
sorbent assay kit (Cusabio, Wuhan, Hubei, China) with a detection
range of 0.156e10 ng/mL according to themanufacturer’s instructions.
2.9. Statistics
Statistical analyses were performed using Sigma Plot software
version 12.0. Data were expressed as mean  standard error of
means. All data were analyzed using 1-way analysis of variance
(ANOVA) followed by post hoc Tukey test, except for repetitive data
which were analyzed by 2-way ANOVA with repeated measures
followed by Tukey test. p-values< 0.05 were considered signiﬁcant.
Fig. 2. Hippocampal extracellular ACh concentrations. Following collection of 3 basal
samples, the perfusion medium was replaced with another medium which contained
atropine sulfate (10 mm) for 1 hour, and then the hippocampus was perfused with the
original medium which did not contain atropine. Microdialysates were collected every
30 minutes for a total of 6 hours. Data are expressed as mean  SEM. * p < 0.001 and a p
< 0.05 compared with respective time points in control-diet group, # p < 0.001 and b p
< 0.05 compared with respective time points in 4 weeks FC diet group using. Abbre-
viations: ACh, acetylcholine; FC, Fortasyn connect; SEM, standard error of the mean.
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3.1. ACh release
Average levels of extracellular ACh in 3 baseline samples were 2.9
 0.1, 5.1  0.4, and 6.5  0.4 pmol/30 minutes in rats supplemented
with control, FC (4 weeks), and FC (6 weeks) diets, respectively.
Compared with the control group, supplementation with FC diet for
4 or 6 weeks signiﬁcantly enhanced (by 1.75- and 2.24-fold, respec-
tively; p < 0.001 for each) average baseline extracellular ACh
concentrations.
Atropine stimulation enhanced hippocampal extracellular ACh
concentrations by a maximum of 6.5-fold (from mean baseline
concentration of 2.9e18.6 pmol/30 minutes) at 30 minutes in
control diet-treated rats although it enhanced hippocampal extra-
cellular ACh concentrations by a maximum of 7-fold (from mean
baseline concentration of 5.1e35.5 pmol/30 minutes) or 8.8-fold
(from mean baseline concentration of 6.5e56.9 pmol/30 minutes)
in rats consuming the FC diet for 4 or 6 weeks, respectively (Fig. 2).
The enhancements in ACh concentrations in FC 4 weeks and FC
6 weeks groups were signiﬁcantly larger compared with those in
control group, and signiﬁcantly higher extracellular ACh concen-
trations were measured in FC 6 weeks group compared with the FC
4 weeks group up to 2 hours after the onset of atropine stimulation
(Fig. 2). Two-way ANOVA revealed a signiﬁcant effect of dose (F[2,
11] ¼ 32.965; p < 0.001), time (F[2, 11] ¼ 97.666; p < 0.001), and a
signiﬁcant interaction of dose and time (F[2, 22] ¼ 9.276; p <
0.001).Fig. 3. Hippocampal tissue ACh (A) and choline (B) content. Rats were sacriﬁced
immediately after microdialysis experiments, and left hippocampi were obtained and
homogenized to measure tissue ACh and choline content. Data are expressed as mean
 SEM. * p < 0.05 and ** p < 0.001 compared with control group. Abbreviations: ACh,
acetylcholine; SEM, standard error of the mean.3.2. Tissue ACh and choline content
ACh levels in left hippocampi of rats in the control, FC 4 weeks
and FC 6 weeks groups were 19412, 249 11, and 290 17 pmol/
mg protein, respectively (Fig. 3A). Compared with control group,
tissue ACh contentwas signiﬁcantly greater in FC 4weeks (p< 0.05)
and FC 6 weeks (p < 0.001) groups (Fig. 3A). On the other hand,
tissue choline content was not statistically different in the control(331  18 pmol/mg protein), FC 4 weeks (334  16 pmol/mg pro-
tein), and FC 6 weeks groups (353  24 pmol/mg protein) (Fig. 3B).
3.3. Tissue phospholipid levels
Treatment with FC diet increased the contents of total and in-
dividual phospholipids in hippocampi of aged rats. Compared with
the control group (321  15 nmol/mg protein), FC diet for 4 or
6 weeks enhanced levels of total phospholipids in the hippocampus
signiﬁcantly by 1.2- (388  11 nmol/mg protein; p < 0.05) or 1.4-
(447  13 nmol/mg protein; p < 0.001) fold, respectively (Table 2).
Levels of PC, PE, and PIwere enhanced by supplementationwith FC
diet for 4 weeks by 1.3-, 1.4-, and 1.3-fold (p < 0.05 for each), respec-
tively (Table 2). Supplementation with FC diet for 6 weeks enhanced
levels of PC, PE, PI, PS, and SM by 1.5- (p< 0.001), 1.5- (p< 0.001), 1.4-
(p< 0.05),1.3- (p< 0.05), and1.3- (p< 0.05) fold, respectively (Table 2).
3.4. Levels of synaptic proteins
Dietary enrichment with FC diet for 6 weeks signiﬁcantly
enhanced levels of presynaptic and postsynaptic proteins while
decreasing those of Nogo-A, a neurite outgrowth inhibitor.
Table 2
Hippocampal phospholipid levels
Groups Phospholipids (nmol/mg protein)
Total phospholipids PC PE PI PS SM
Control 321  15 139  8 124  5 9.8  0.7 24.3  1.2 12.3  0.6
FC diet (4 wk) 388  11* 187  8* 171  6* 13.2  0.9* 28.9  1.1 14.5  0.9
FC diet (6 wk) 447  13**,y 202  9** 190  8** 13.7  0.8* 30.9  1.4* 15.8  0.9*
* p < 0.05 and ** p < 0.001 compared with control and y p < 0.05 compared with FC diet (4 weeks).
Key: FC, Fortasyn connect; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI, phosphatidylinositol; PS, phosphatidylserine; SM, sphingomyelin.
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PSD-95 (Fig. 4B) increased by 78% (p < 0.001) and 75% (p < 0.05) in
rats receiving the FC diet for 6 weeks, respectively. On the contrary,
levels of Nogo-A were decreased by 66% (p < 0.05) in FC 6 weeks
group (Fig. 4C). Although treatment with FC diet for 4 weeks tended
to enhance levels of presynaptic and postsynaptic proteins and
decrease those of Nogo-A, the effect did not reach statistical sig-
niﬁcance (Fig. 4).
3.5. ChAT levels
Treatment with FC diet for 6 weeks signiﬁcantly enhanced ChAT
levels compared with the control group (1.049  0.02 vs 0.868 
0.06 ng/mg protein; p < 0.05). Although treatment with FC diet for
4 weeks tended to enhance ChAT levels, the effect did not reach
statistical signiﬁcance (Fig. 5).
4. Discussion
The present data show that dietary enrichment with FC of aged
rats signiﬁcantly enhances hippocampal ACh levels and release,Fig. 4. Levels of synaptic proteins in the hippocampus. Synapsin-1 (A), PSD-95 (B) and Nogo-
structural protein, levels of which did not differ between treatment groups, was used as pro
curve were expressed as arbitrary units and normalized as percentages of those generated
0.001 compared with control group and # p < 0.05 compared with 4 weeks FC diet group.indicating enhanced cholinergic neurotransmission in the hippo-
campus, which was accompanied by increased levels of total and
major individual phospholipids, ChAT, and the synaptic proteins
Synapsin-1 and PSD-95, but decreased levels of the neurite
outgrowth inhibitor, Nogo-A. These data suggest that previously
observed positive effects of dietary supplementation with FC on
learning and memory (Scheltens et al., 2010, 2012) may at least in
part be ascribed to the enhancement of hippocampal cholinergic
neurotransmission.
FC is a speciﬁc nutrient combination containing nutritional
precursors and cofactors that act together to support neuronal
membrane formation and function. In this way, FC hypothetically
improves processes relevant in AD that are partly or largely
dependent on membrane formation and function, for example,
synapse formation, neurotransmission, and memory performance
(Van Wijk et al., 2014). The precursors for membrane synthesis
provided by FC (DHA, eicosapentaenoic acid, uridine, and choline)
act by enhancing the substrate-saturation of the enzymes that
catalyze the rate-limiting steps in the synthesis of phospholipids,
the main constituents of neuronal membranes (Wurtman et al.,
2009). Other nutrients in FC (B-vitamins, vitamin C, vitamin E,A (C) were assayed by Western blot using homogenates of left hippocampi. b-tubulin, a
tein loading control. Protein bands were given in panel D. Areas under the absorbance
in the same blot using samples from hippocampi of control animals. * p < 0.05, ** p <
Abbreviation: FC, Fortasyn connect.
Fig. 5. Hippocampal ChAT levels. Levels of ChAT in left hippocampi were assayed by
ELISA method using a commercial rat ChAT kit. ChAT levels were expressed as ng/mg
protein. Data are expressed as mean  SEM. * p < 0.05 compared with control group.
Abbreviations: ChAT, choline acetyltransferase; ELISA, enzyme-linked immunosorbent
assay; FC, Fortasyn connect; SEM, standard error of the mean.
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availability of membrane precursors or by directly affecting the
neuronal membrane or membrane synthesis (VanWijk et al., 2014).
Various in vitro and in vivo studies have previously shown effects of
supplementation with combinations of membrane precursors and
cofactors on phospholipid synthesis (e.g., Wurtman et al., 2006),
neurite outgrowth (e.g., Pooler et al., 2005), levels of speciﬁc pre-
synaptic and postsynaptic proteins (e.g., Cansev and Wurtman,
2007), number of dendritic spines (e.g., Sakamoto et al., 2007),
neurotransmitter levels and release (e.g., Cansev et al., 2008; Wang
et al., 2007), receptor signaling (e.g., Savelkoul et al., 2012), and
cognitive performance (e.g., de Wilde et al., 2011; Holguin et al.,
2008a, 2008b; Koivisto et al., 2014; Wiesmann et al., 2013). The
clinical studies to date show that an FC-containing medical food
improves memory function in early AD patients (Scheltens et al.,
2010, 2012) and preserves functional brain network organization
as measured by electroencephalography (de Waal et al., 2014).
In the current in vivo study, we further explored the physiological
mechanism underlying the cognitive enhancing effects of mem-
brane precursors and cofactors by using the speciﬁc nutritional
composition tested in these clinical trials.
Because improved learning and memory in various tasks is
associated with enhanced cholinergic neurotransmission in the
hippocampus (Fadda et al., 2000; Nail-Boucherie et al., 2000), we
investigated the effect of FC diet supplementation on ACh release by
in vivo microdialysis in aged rats. We found that supplementation
with FC diet for 4 or 6 weeks signiﬁcantly enhanced basal release of
ACh in the hippocampus by 1.75- and 2.24-fold as comparedwith the
control group, respectively. In addition, atropine-stimulated release
of ACh in the hippocampuswas enhanced by feeding the FC diet for 4
or 6weeks by amaximumof 7- and 8.8-fold, respectively, as opposed
to 6.5-fold in control group. Hence, the effect of FC supplementation
was time dependent, and treatment for more than 6 weeks may
further increase the basal and stimulated ACh release.
As discussed later, the enhanced ACh release under baseline and
atropine-stimulated conditions is probably because of the increased
levels of presynaptic membrane-dependent elements including
presynaptic boutons and vesicles along with an increased ACh syn-
thesis. The enhancements are probably not because of a decrease
in ACh catabolism as was shown in a previous study with UMP
treatment (Wang et al., 2007) and our unpublished observationswhere we found no effects on acetylcholinesterase activity when
feeding 21- to 24-month-old rats an FC-enriched diet (N. van Wijk,
M.C. deWilde and L. M. Broersen, unpublished results). Additionally,
the enhancement in atropine-stimulated ACh release could be
explained by autoregulation of presynapticmuscarinic receptors. The
release of ACh from central cholinergic neurons is believed to be
subject to autoregulation, whereby the neurotransmitter released
interacts with presynaptic muscarinic receptors to inhibit the further
release of neurotransmitter (Chesselet, 1984). It is therefore possible
that the greater hippocampal extracellular ACh concentrations under
baseline conditions in FC-treated rats provided a greater inhibition in
ACh release through stimulation of presynaptic muscarinic autor-
eceptors, which in turn led to the enhanced release of ACh compared
with control rats upon blockade of these receptors by atropine.
Our ﬁndings on enhancedACh releasewith FC dietary enrichment
are in line with previous reports which also tested effects of mem-
brane precursors (choline, DHA, and uridine) on cholinergic trans-
mission. For example, a choline enriched diet fed to rats was
previously shown to increase basal and/or stimulated cortical and
hippocampal release of ACh in rats (Beninger et al., 1984; Köppen
et al., 1997). Dietary supplementation with DHA-containing phos-
pholipids has been demonstrated to restore aging-induced re-
ductions in hippocampal basal and stimulatedACh release (Favrelière
et al., 2003). While basal ACh release was enhanced by 29%e59%,
high-potassium-stimulated ACh release was enhanced by about 32%
in 18-month-old rats fed the diet with DHA-containing phospho-
lipids for 3 months (Favrelière et al., 2003). Furthermore, dietary
enrichment with omega-3 PUFAs (including DHA) or DHA-
containing phospholipids normalized omega-3 PUFA deﬁciency-
induced changes in hippocampal basal and stimulated ACh release
(Aid et al., 2003, 2005). In support of our present data, consumption
of a diet containing UMP and standard levels of choline by young and
aged rats led to augmented striatal ACh levels and increased basal
and stimulated release of ACh in a previous study (Wang et al., 2007).
The authors reported that supplementing aged rats for 1 or 6 weeks
with 2.5% (wt/wt) UMP enhanced basal ACh release in striatum by,
respectively, 2.0- and 2.7-fold versus controls (Wang et al., 2007).
Consumption of a diet with lower levels (0.5%; wt/wt) of UMP for
1 week increased baseline ACh levels by 1.2-fold along with an
enhancement in atropine-stimulated ACh release by 5.0-fold (Wang
et al., 2007). Our present data are in line with previous ﬁndings
reporting an enhancement in cholinergic neurotransmission after
nutritional supplementation. On the other hand, a comparison with
regard to the extent of the increase in ACh release and levels reported
in these previous studies and our present results may not be
reasonable because of the differences in experimental setup (e.g.,
brain region, age of animals, duration, nutrient levels). Further
investigation should therefore focus on a comparison of efﬁcacy of
different combinations of nutrients.
The enhancement in hippocampal ACh release by dietary
intervention with FC was accompanied by increased tissue con-
tent of ACh in the hippocampus. Moreover, levels of ChAT, the
enzyme which mediates the synthesis of ACh from choline and
acetyl-CoA, were enhanced by the FC diet, suggesting that syn-
thesis of ACh was elevated. This suggestion is further supported
by the present ﬁnding that the tissue content of choline did not
change. This indicates that the additional choline in the FC diet
made available for the brain was directly or indirectly used for
ACh formation. Indirectly, FC-induced increased brain levels of PC
and SM (as discussed in the following), for which choline is used,
also could be a source of additional choline for ACh synthesis.
Because brain levels of PC (and SM) are orders of magnitude
greater than those of ACh, the 45% increase in PC in the present
study could readily provide sufﬁcient choline for the observed
increases in ACh.
M. Cansev et al. / Neurobiology of Aging 36 (2015) 344e351350The present data on ChAT levels add up to the results of a pre-
vious study which showed that the reduction of ChAT immunore-
activity in Ab42-infused rats was prevented in those receiving an
FC-enriched diet (de Wilde et al., 2011). The increased tissue ACh
levels found in the present study are also in line with previous
publications (Cohen and Wurtman, 1976; Wang et al., 2007),
reporting increased ACh tissue levels after supplementation with
membrane precursors.
Although we found a nonsigniﬁcant 15% increase in ChAT by
4 weeks FC diet treatment compared with the control group, we
observed a signiﬁcant 29% increase in hippocampal ACh content
and a signiﬁcant 1.9-fold increase in ACh release following atropine
stimulation. In addition, compared with the control group, 6 weeks
FC diet treatment increased the levels in the hippocampus of ChAT
with 21%. This discrepancy between the magnitude of effects on
Ach levels and release and ChAT levels might be explained by an
increase in the activity of ChAT enzyme. Further studies are needed
to investigate the effect of FC diet on ChAT enzyme activity.
The FC-induced increase in hippocampal ACh content and
release might involve enhanced synaptic membrane formation
and consequently enhanced synapse formation. We therefore
analyzed levels of phospholipids and synaptic proteins in hippo-
campal tissue samples of aged rats. We found that consumption of
the FC diet for 4 or 6 weeks signiﬁcantly enhanced the levels of
total and individual phospholipids, including PC, the major
membrane phospholipid. The cellular loci of the increased mem-
brane phospholipids probably include synaptic vesicles and syn-
aptic membranes, because the FC diet also raised the levels of the
presynaptic vesicular protein Synapsin-1 and the postsynaptic
protein PSD-95. Hence, supplementation with FC may produce
more or larger synapses or synaptic vesicles which may contribute
to increasing hippocampal ACh content and release. In accordance
with our ﬁndings, the increase in amounts of membrane phos-
pholipids after oral supplementation of DHA and/or UMP reported
in previous studies (Cansev and Wurtman, 2007; Cansev et al.,
2008, 2009; Sakamoto et al., 2007; Wurtman et al., 2006) were
also shown to be associated with increased levels of speciﬁc pre-
synaptic and postsynaptic proteins.
Interestingly, in contrast to the enhancement in synaptic pro-
teins, levels of Nogo-A, a myelin-associated protein which inhibits
neurite growth (Chen et al., 2000), were reduced signiﬁcantly after
6 weeks of FC diet treatment. Nogo-A is expressed by both oligo-
dendrocytes and neurons in the aged hippocampal formation and
over-expressed by hippocampal neurons in AD (Gil et al., 2006). In
addition, Nogo-A and its receptor have been localized in synaptic
contacts (Liu et al., 2003) and the blockade of Nogo-A enhances
axonal sprouting and synapse formation in neurons (Blochlinger
et al., 2001). Therefore, our present data suggest that the FC diet
not only reduced the Nogo-A-induced inhibition of neurite
outgrowth but may also help reduce the inhibitory effects of Nogo-
A on neuronal plasticity and the formation of new synaptic con-
tacts, as supported by the present evidence on synaptic proteins.
As observed in the current experiment, the increased formation
of synaptic membranes and/or an increased ACh synthesis may
enhance hippocampal neurotransmission, and collectively this may
partly underlie the cognitive enhancing effects of FC. Nevertheless,
the effects of the FC diet are probably not speciﬁc for cholinergic
synapses and the effects are likely not only conﬁned to the hippo-
campus. For example, supplementation of rodents with phospho-
lipid precursors has previously been shown to enhance levels of
hippocampal mGluR1 receptors (Sakamoto et al., 2007), along with
those of Synapsin-1 and PSD-95, indicating an involvement of
glutamatergic neurotransmission. Additionally, dietary supple-
mentation with UMP has previously also been shown to increase
striatal levels of dopamine in aged rats (Wang et al., 2005).Therefore, it is highly possible that changes in other neurotrans-
mitter systems may have contributed to the previously observed
improvements with the FC nutrient combination in experimental
and clinical studies. Further studies will be conducted to investigate
the possible involvement of other systems that may underlie the
cognitive enhancing effects of FC.
In conclusion, chronic consumption of the combination of the
membrane precursors and cofactors contained within FC by aged
rats enhances hippocampal cholinergic neurotransmissionwhich is
paralleled by increased synthesis of synaptic membranes. This is
the ﬁrst study to present a combined data set which provides
further insight into cellular and molecular mechanisms by which
combined supplementation of nutrients that are deﬁcient in AD
may support mnemonic processes.
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